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Objectives. The aim of this pilot study was to assess the prevalence of co-morbidity in obese
children. Particular emphasis was on cardiovascular risk.
Method. In this retrospective, cross-sectional, observational study the data of 155 obese chil-
dren, who visited a paediatric obesity outdoor clinic, have been studied.
Results. In all, 92% of the population had at least one cardiovascular risk factor. In all, 48%
showed a high systolic and 9% a high diastolic blood pressure, while 18% had an increased fast-
ing glucose. In 60%, we diagnosed insulin resistance: the homeostasis model assessment was
elevated.
Discussions. The prevalence of high blood pressure, dyslipidaemia, abnormal fasting glucose
and insulin resistance are high in this retrospective study. Outcomes of foreign studies on this
object are difficult to compare because various populations and cut-off points are used. A
new, prospective, study will be conducted to asses the prevalence of co-morbidity in obese chil-
dren in general practice.
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Introduction
Obesity is increasing worldwide. Since the effects of in-
tervention in adult obesity are disappointing, preven-
tion of adult obesity is in our opinion the approach of
choice. This prevention strategy should start in child-
hood. In 2002, the prevalence of childhood obesity in
Europe had already exceeded the predicted peak for
2010.1 The prevalence of childhood obesity in The
Netherlands in 2003 was 2.6% of the boys and 3.3% of
the girls, still relatively low but increasing in compari-
son with 1997.2 Childhood obesity is not only a risk fac-
tor for adult obesity,3 but associated with hypertension,
dyslipidaemia and insulin resistance as well.4,5
In The Netherlands, a multidisciplinary task force
group of the Dutch Institute for Healthcare Improve-
ment (CBO) (including general practice) has devel-
oped an evidence-based guideline on primary and
secondary prevention of obesity.6 In this guideline,
the Dutch GPs are asked to actively diagnose and en-
gage obese children. Currently, we are preparing
a primary care-based multidisciplinary project on
childhood obesity on the basis of this guideline. An
important element of this guideline is its focus on co-
morbidity. However, the prevalence of co-morbidity
in obese children in the general practice population,
assumed to be high, has never been studied in The
Netherlands. In our view, it would stimulate GPs par-
ticipation in the guideline, when empirical evidence of
co-morbidity in obese children in their practices would
be available. We report here a pilot study that aimed
to assess the prevalence of co-morbidity in obese chil-
dren who had been diagnosed by their GP and/or
youth health care. Particular emphasis was on cardio-
vascular risk (high blood pressure, dyslipideamia, fast-
ing glucose and insulin resistance).
Patients and materials
In Amersfoort (a city in the centre of The Nether-
lands, 135 000 inhabitants), an alliance formed by
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youth health care, paediatricians and GPs has already
developed a regional protocol for obese children in
2005 in which an obesity outdoor clinic of the Mean-
der Medical Centre Amersfoort (Poli X) served as the
facility to supervise care and support of all obese chil-
dren and their parents.7 This is the only paediatric out-
door clinic specialized in childhood obesity in the region.
Participants
For this study, we analysed the data of the first 155 pa-
tients that had been included in the project (60 boys
and 95 girls, 57% Dutch origin and 43% immigrants).
The inclusion criteria were the diagnosis obesity and
the age of 2–18 years. The patients had been recruited
by their GP or by youth health care and they visited
Poli X between November 2005 and July 2007.
Methods
Of each child, weight, height, body mass index (BMI),
BMI-standard deviation score (SDS), blood pressure,
fasting glucose, fasting insulin, homeostasis model as-
sessment (HOMA), fasting triglycerides, fasting low-
density lipoprotein cholesterol (LDL-c) and fasting
high-density lipoprotein cholesterol (HDL-c) were
measured according to the Poli X protocol. This pro-
tocol is summarized in Table 1 and is almost similar
to the CBO protocol.
BMI. Height and weight (both Seca scales) had been
measured and BMI was calculated. Obesity was defined
according to the 97th percentile using population-
specific data in concordance with the definition of
obesity of the International Task Force of Obesity.8 In
contrast to adults, in children and adolescents the cut-
off points for BMI depend on and sex.
BMI-SDS. BMI-SDS according to Dutch reference.9
Blood pressure. Systolic blood pressure (SBP) and
diastolic blood pressure (DBP) were measured at the
right arm after a 5-minute rest in a seated position.
The correct cuff had to be used for the length and cir-
cumference of the right upper arm: at least a third of
the upper arm had to be covered. If the result was
high (>P95), the procedure was repeated twice. The
lowest result has been used for the study. Blood pres-
sure was corrected for age, gender and height.10
Blood samples. Blood samples were obtained by
a trained laboratory technician in the laboratory of
the Meander Medical Centre in Amersfoort. Instruc-
tion had been given to fast for at least 8 hours. Fasting
glucose, fasting insulin and fasting lipids were mea-
sured. We have used laboratory techniques and cut-off
points according to the guidelines of Poli X (Table 2).
Insulin resistance. The insulin resistance was assessed
by the formula11:
HOMA=
insulin ðmilli units per literÞglucose ðmMÞ
22:5
:
Results
The mean age was 10.8 years (range 3.1–18.6) and the
mean BMI-SDS 2.8 (range 2.0–4.6). Children and pa-
rents were very cooperative. None of the children re-
fused examination. There are some missing data:
blood pressure (n = 10) and results of fasting glucose
(n = 2) and fasting insulin (n = 13). Of the 155 chil-
dren, 92% had at least one cardiovascular risk factor.
We diagnosed one cardiovascular risk factor in 93%
of the autochthon children (mean BMI-SDS 2.76) and
in 89% of the immigrant children (mean BMI-SDS
2.91). In 48%, a high SBP and in 9% a high DBP was
found, while 18% had an increased fasting glucose. In
60%, the HOMA was elevated. The results are shown
in Figure 1.
TABLE 1 Summary protocol Poli X, Meander Medical Centre
Amersfoort
TABLE 2 Laboratory tests and cut-off points according to protocol
Poli X, Meander Medical Centre Amersfoort
Test Poli X Cut-off point
Poli X
HDL Homogeneous direct analysis
(Beckman Coulter LXi)
1.1
LDL Calculation Friedenwald
(Beckman Coulter LXi)
4
TG Enzymatic analysis (GPO-trinder)
(Beckman Coulter LXi)
1.5
Chol Enzymatic analysis
(Beckman Coulter LX)i
6–12 years: 5.5
12–18 years: 6.5
Insulin Chemoluminescense assay
(Immulite 2000)
–
Glucose Enzymatic analysis with glucose
oxidase (Beckman Coulter LX)
5.6
HOMA 3.1
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Discussion
The results confirm a substantial prevalence of co-
morbidity in obese children and give an indication of
what can be expected from a surveillance of the general
practice population. In other countries, similar studies
have been conducted with comparable results, although
often different populations and cut-off points were used.
An important experience was that the protocol was ac-
cepted by the patients and their parents. Although we
did not measure it explicitly, the health care professio-
nals involved, also showed enthusiasm for this project.
The German study of Reinehr et al.4 indicates that
70% of all the obese children suffered from at least
one cardiovascular risk factor. In this group (4–18
years old), 37% of the children had hypertension,
27% a high total cholesterol and 26% a high LDL-c
and 26% a low HDL-c.
Li et al.5 studied the relative risk on dyslipidaemia,
hypertension, diabetes mellitus and the metabolic syn-
drome in obese children in relation to normal weight
children in China. The relative risk for dyslipdaemia
in obese children was 1.8 and for hypertension 2.9.
The metabolic syndrome was diagnosed in 83.3% of
the obese children. The review article of Amemiya
et al.12 indicates that the metabolic syndrome in chil-
dren and adolescents has become prevalent in the re-
cent years. They found a high variation in prevalence
of youth metabolic syndrome. This variation can be
partly explained by the lack of standardization in the
definition of anthropometric variables and difference
in cut-off points used in the studies.
The pilot study forms the basis for a prospective
study in 2008. Obese children who will be recruited by
GPs (Group 1, n = 50) or by youth health care (Group
2, n = 50) to the Poli X will be studied. The principal
objective of this study is to assess the prevalence of co-
morbidity in obese children in general practice in The
Netherlands. A control group of normal weight chil-
dren in general practice (Group 3, n = 50) will be in-
cluded. The same protocol will be used as in the pilot
study. We will try to validate, a non-invasive, diagnostic
instrument enabling GPs to detect high-risk obese
children in the daily practice. For this reason, a waist
circumference measurement and a bioelectrical imped-
ance analysis will be added to the examination of the
obese children (Groups 1 and 2) (Bio impedance Ana-
lyzer Model BIA 101; Akern Srl, Florence, Italy).
Our pilot study has revealed some important issues
requiring special attention in the prospective study.
To choose cut-off points for the pilot study was diffi-
cult. In this study, we used the cut-off points defined
by Poli X. Since there was no consensus about the di-
agnosis of metabolic syndrome in children, we did not
include the syndrome in the pilot study. We decided
to use the recent published definition of the Interna-
tional Diabetes Federation13 for metabolic syndrome
in children in our prospective study (Table 3). This ar-
ticle was published after we finished our pilot study.
The HDL cut-off point in this definition is lower than
the one we used in our pilot study. Maybe that is an
explanation for the high percentage of children with
an abnormal HDL. The CBO consensus was finished
after we conducted the pilot study. In this protocol,
the QUICKY (quantitative insulin sensitivity check in-
dex) has been chosen as a measure for insulin resistance.
We will add a QUICKY to the Poli X protocol. In
the prospective study, we will study the relation of co-
morbidity with age, cardiovascular risk factors in the
family and ethnicity. In this study, we found for instance
a higher percentage of co-morbidity in Dutch-born chil-
dren in spite of a lower mean BMI-SDS.
FIGURE 1 Results pilot study Poli X, Meander Medical CentreAmersfoort
i77Co-morbidity obese children in family practice in The Netherlands
 at K
atholieke U
niversiteit on July 11, 2012
http://fam
pra.oxfordjournals.org/
D
ow
nloaded from
 
In summary, we have found a high percentage of co-
morbidity in obese children in our pilot study. If the
prevalence of this co-morbidity is as high in the group
obese children who are sent by GP to Poli X (Group 1)
and significantly higher than in normal weight children
(Group 3), it will be a strong argument for GPs to im-
plement the national CBO guideline.
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TABLE 3 The IDF definition of the at-risk group and MetS in children and adolescents13
Age group
(years)
Obesity (WC) Triglycerides HDL-c Blood
pressure
Glucose or
known T2DM
6 to <10 >90th percentile MetS cannot be diagnosed, but further measurements should be made if there is a family history of
MetS, T2DM, dyslipidemia, CVD, hypertension and/or obesity.
10 to <16 >90th percentile
or adult cut-off
point if lower
>1.7 mmol/l <1.03 mmol/l Systolic
>130 mmHg
or diastolic
>85 mmHg
>5.6 mmol/l (or
known T2DM) (if
>5.6 recommend
an OGTT)
16+ Use existing IDF criteria for adults14
IDF, International Diabetes Federation; WC, waist circumference; HDL-c, high-density lipoprotein cholesterol; MetS, metabolic syndrome;
T2DM, type 2 diabetes mellitus; CVD, cardiovascular disease; OGTT, oral glucose tolerance test.
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